Osteoporosis

 

Osteoporosis, a condition where the density of bone-mass decreases leading to fragile, weakened bones, has been strongly linked to homocystinuria (elevated urinary homocysteine) and associated with high homocysteine levels. Postmenopausal women are particularly at risk from low oestrogen levels. This in turn appears to raise homocysteine and increase the chance of developing osteoporosis later on in life.

 

A Japanese study followed 628 patients aged 65 years or older for one year after suffering a stroke. A dramatic increase in the number of subsequent hip fractures was evident, twice to four times higher than that expected in age-matched healthy control patients. Patients with homocystinuria also had an increased prevalence of skeletal abnormalities, including osteoporosis, which is a primary risk factor for hip fracture. Elevated homocysteine concentrations appears to be independently associated with both osteoporosis and the increased risk of hip fracture.

Homocysteine Testing

To find out more about the different Homocysteine assays available from Axis-Shield, visit www.axis-shield.com

NEW Instrument Applications

ABX PENTRA 400

MINDRAY BS-400 (SPIN 640)

 

Latest Publications

Homocysteine and Reclassification of Cardiovascular Disease Risk


 Associations Between Elevated Homocysteine, Cognitive Impairment, and Reduced White Matter Volume in Healthy Old Adults.


Towards the Identification of Blood Biomarkers for acute stroke in humans: a comprehensive systematic review.


For full details visit the Publications page.

© Axis-Shield plc. All rights reserved. Terms of Use | Accessibility
E: homocysteine@axis-shield.com - T: +44 13 8242 2000 - F: +44 1382 422088